NPR News: Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic
Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why.

Read more on NPR
Health & Science - January 20, 2020 at 09:00PM - Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic